Results 141 to 150 of about 5,894,644 (362)

Integrative analysis of circulating tumor cells (CTCs) and exosomes from small‐cell lung cancer (SCLC) patients: a comprehensive approach

Molecular Oncology, EarlyView.
This study simultaneously investigated circulating tumor cells (CTCs) and exosomes from small‐cell lung cancer (SCLC) patients. The elevated expression of JUNB and CXCR4 in CTCs was a poor prognostic factor for SCLC patients, whereas exosomal overexpression of these biomarkers revealed a high discrimination ability of patients from healthy individuals,
Dimitrios Papakonstantinou, Argyro Roumeliotou, Evangelia Pantazaka, Athanasios‐Nasir Shaukat, Athina Christopoulou, Angelos Koutras, Foteinos‐Ioannis Dimitrakopoulos, Vassilis Georgoulias, Anastasia Xagara, Evangelia Chantzara, Fillipos Koinis, Athanasios Kotsakis, Constantinos Stathopoulos, Galatea Kallergi   +13 more
wiley   +1 more source

MOLECULAR ASPECTS OF HUMAN T LYMPHOCYTE ANTIGEN RECOGNITION

, 1985
Hans Dieter Royer, Thomas J. Campen, Dunia Ramarli, Hsiu‐Ching Chang, Oreste Acuto, Ellis L. Reinherz   +5 more
openalex   +1 more source

Molecular model of the specificity pocket of the hepatitis C virus protease: implications for substrate recognition. [PDF]

, 1994
Elisabetta Pizzi, Anna Tramontano, Licia Tomei, Nicola La Monica, Cristina Maria Failla, M K Sardana, Theresa Wood, Raffaele De Francesco   +7 more
openalex   +1 more source

Detection rate for ESR1 mutations is higher in circulating‐tumor‐cell‐derived genomic DNA than in paired plasma cell‐free DNA samples as revealed by ddPCR

Molecular Oncology, EarlyView.
Analysis of ESR1 mutations in plasma cell‐free DNA (cfDNA) is highly important for the selection of treatment in patients with breast cancer. Using multiplex‐ddPCR and identical blood draws, we investigated whether circulating tumor cells (CTCs) and cfDNA provide similar or complementary information for ESR1 mutations.
Stavroula Smilkou, Aliki Ntzifa, Victoria Tserpeli, Ioanna Balgkouranidou, Alkistis Papatheodoridi, Evangelia Razis, Helena Linardou, Christos Papadimitriou, Amanda Psyrri, Flora Zagouri, Stylianos Kakolyris, Evi Lianidou   +11 more
wiley   +1 more source

Investigation of Peptides for Molecular Recognition of C-Reactive Protein-Theoretical and Experimental Studies. [PDF]

Anal Chem, 2023
Szot-Karpińska K, Kudła P, Orzeł U, Narajczyk M, Jönsson-Niedziółka M, Pałys B, Filipek S, Ebner A, Niedziółka-Jönsson J.   +8 more
europepmc   +1 more source

Cell targetability of liposomes bearing molecular recognition site.

, 1989
Toshinori Sato, Kazunari Akiyoshi, Junzo Sunamoto   +2 more
openalex   +2 more sources

Molecular recognition of neutral molecules by rigid binaphthyl metalloclefts: Synthesis, complexation and calculations [PDF]

, 1992
Arie R. Van Doorn, David J. Rushton, Willem Verboom, David N. Reinhoudt, M. G. Bos   +4 more
openalex   +1 more source

Cell‐free DNA aneuploidy score as a dynamic early response marker in prostate cancer

Molecular Oncology, EarlyView.
mFast‐SeqS‐based genome‐wide aneuploidy scores are concordant with aneuploidy scores obtained by whole genome sequencing from tumor tissue and can predict response to ARSI treatment at baseline and, at an early time point, to ARSI and taxanes. This assay can be easily performed at low cost and requires little input of cfDNA. Cell‐free circulating tumor
Khrystany T. Isebia, Anouk C. de Jong, Lisanne F. van Dessel, Vanja de Weerd, Corine Beaufort, Jean Helmijr, José Alberto Nakauma‐González, Job van Riet, Paul Hamberg, Daniel Vis, Michiel S. van der Heijden, Nick Beije, Martijn P. Lolkema, Teoman Deger, Saskia M. Wilting, Ronald de Wit, Maurice P. H. M. Jansen, John W. M. Martens   +17 more
wiley   +1 more source

Biosensors with Metal Ion-Phosphate Chelation Interaction for Molecular Recognition. [PDF]

Molecules, 2023
Ma X, Hao Y, Dong X, Xia N.
europepmc   +1 more source

Design and characterization of molecular recognition site of bioaffinity sensor.

, 1987
Masuo Aizawa, Yoshihito Ikariyama
openalex   +2 more sources